<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T05:13:09Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5015289" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:5015289</identifier>
        <datestamp>2016-09-19</datestamp>
        <setSpec>jaha</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Am Heart Assoc</journal-id>
              <journal-id journal-id-type="iso-abbrev">J Am Heart Assoc</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)2047-9980</journal-id>
              <journal-id journal-id-type="publisher-id">JAH3</journal-id>
              <journal-id journal-id-type="hwp">ahaoa</journal-id>
              <journal-title-group>
                <journal-title>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2047-9980</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC5015289</article-id>
              <article-id pub-id-type="pmcid">PMC5015289</article-id>
              <article-id pub-id-type="pmc-uid">5015289</article-id>
              <article-id pub-id-type="pmid">27543307</article-id>
              <article-id pub-id-type="pmid">27543307</article-id>
              <article-id pub-id-type="doi">10.1161/JAHA.116.003666</article-id>
              <article-id pub-id-type="publisher-id">JAH31645</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Original Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Research</subject>
                  <subj-group subj-group-type="heading">
                    <subject>Arrhythmia and Electrophysiology</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Obstructive Sleep Apnea and Circulating Potassium Channel Levels</article-title>
                <alt-title alt-title-type="left-running-head">Jiang et al</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="jah31645-cr-0001" contrib-type="author">
                  <name>
                    <surname>Jiang</surname>
                    <given-names>Ning</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="jah31645-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jah31645-cr-0002" contrib-type="author">
                  <name>
                    <surname>Zhou</surname>
                    <given-names>Anyu</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <xref ref-type="aff" rid="jah31645-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jah31645-cr-0003" contrib-type="author">
                  <name>
                    <surname>Prasad</surname>
                    <given-names>Bharati</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="jah31645-aff-0003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jah31645-cr-0004" contrib-type="author">
                  <name>
                    <surname>Zhou</surname>
                    <given-names>Li</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <xref ref-type="aff" rid="jah31645-aff-0003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jah31645-cr-0005" contrib-type="author">
                  <name>
                    <surname>Doumit</surname>
                    <given-names>Jimmy</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="jah31645-aff-0003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jah31645-cr-0006" contrib-type="author">
                  <name>
                    <surname>Shi</surname>
                    <given-names>Guangbin</given-names>
                  </name>
                  <degrees>MD, MS</degrees>
                  <xref ref-type="aff" rid="jah31645-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jah31645-cr-0007" contrib-type="author">
                  <name>
                    <surname>Imran</surname>
                    <given-names>Hafiz</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="jah31645-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jah31645-cr-0008" contrib-type="author">
                  <name>
                    <surname>Kaseer</surname>
                    <given-names>Bahaa</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="jah31645-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jah31645-cr-0009" contrib-type="author">
                  <name>
                    <surname>Millman</surname>
                    <given-names>Richard</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="jah31645-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah31645-cr-0010" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Dudley</surname>
                    <given-names>Samuel C.</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <xref ref-type="aff" rid="jah31645-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="jah31645-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="jah31645-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Lifespan Cardiovascular Institute</named-content>
                <institution>Brown University</institution>
                <named-content content-type="city">Providence</named-content>
                <named-content content-type="country-part">RI</named-content>
              </aff>
              <aff id="jah31645-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Rhode Island Hospital</named-content>
                <institution>Brown University</institution>
                <named-content content-type="city">Providence</named-content>
                <named-content content-type="country-part">RI</named-content>
              </aff>
              <aff id="jah31645-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <institution>University of Illinois at Chicago</institution>
                <named-content content-type="country-part">IL</named-content>
              </aff>
              <aff id="jah31645-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <institution>The Providence VA</institution>
                <named-content content-type="city">Providence</named-content>
                <named-content content-type="country-part">RI</named-content>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Correspondence to:</bold> Samuel C. Dudley, Jr, MD, PhD, The Warren Alpert Medical School of Brown University, 593 Eddy St, APC 814, Providence, RI 02903. E‐mail: <email>samuel_dudley@brown.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>19</day>
                <month>8</month>
                <year>2016</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>8</month>
                <year>2016</year>
              </pub-date>
              <volume>5</volume>
              <issue>8</issue>
              <issue-id pub-id-type="doi">10.1002/jah3.2016.5.issue-8</issue-id>
              <elocation-id>e003666</elocation-id>
              <history>
                <date date-type="received">
                  <day>13</day>
                  <month>4</month>
                  <year>2016</year>
                </date>
                <date date-type="accepted">
                  <day>20</day>
                  <month>6</month>
                  <year>2016</year>
                </date>
              </history>
              <permissions>
                <!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell <copyright-statement>-->
                <copyright-statement content-type="article-copyright">© 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.</copyright-statement>
                <license license-type="creativeCommonsBy-nc">
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution‐NonCommercial</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:JAH3-5-e003666.pdf"/>
              <abstract id="jah31645-abs-0001">
                <sec id="jah31645-sec-0001">
                  <title>Background</title>
                  <p>Cardiac arrhythmias and sudden cardiac death are more frequent in patients with obstructive sleep apnea (<styled-content style="fixed-case">OSA</styled-content>). <styled-content style="fixed-case">OSA</styled-content> is associated with <styled-content style="fixed-case">QT</styled-content> prolongation, and <styled-content style="fixed-case">QT</styled-content> prolongation is an independent risk factor for sudden cardiac death. Because <styled-content style="fixed-case">QT</styled-content> prolongation can be mediated by potassium channel loss of function, we tested whether <styled-content style="fixed-case">OSA</styled-content> or continuous positive airway pressure therapy altered <styled-content style="fixed-case">mRNA</styled-content> expression of circulating white blood cell potassium channels.</p>
                </sec>
                <sec id="jah31645-sec-0002">
                  <title>Methods and Results</title>
                  <p>In total, 28 patients with OSA newly diagnosed by polysomnogram and 6 participants without <styled-content style="fixed-case">OSA</styled-content> were enrolled. Potassium channel levels in white blood cells at baseline and at a 4‐week follow‐up visit were compared. There was a significant inverse correlation between the severity of the <styled-content style="fixed-case">OSA</styled-content> stratified by apnea–hypopnea index and <styled-content style="fixed-case">mRNA</styled-content> expression of the main potassium channels assessed: <styled-content style="fixed-case">KCNQ</styled-content>1 (<italic>r</italic>=−0.486, <italic>P</italic>=0.007), <styled-content style="fixed-case">KCNH</styled-content>2 (<italic>r</italic>=−0.437, <italic>P</italic>=0.016), <styled-content style="fixed-case">KCNE</styled-content>1 (<italic>r</italic>=−0.567, <italic>P</italic>=0.001), <styled-content style="fixed-case">KCNJ</styled-content>2 (<italic>r</italic>=−0.442, <italic>P</italic>=0.015), and <styled-content style="fixed-case">KCNA</styled-content>5 (<italic>r</italic>=−0.468, <italic>P</italic>=0.009). In addition, <styled-content style="fixed-case">KCNQ</styled-content>1, <styled-content style="fixed-case">KCNH</styled-content>2, and <styled-content style="fixed-case">KCNE</styled-content>1 inversely correlated with the oxygen desaturation index 4. After 4 weeks of continuous positive airway pressure therapy, circulating <styled-content style="fixed-case">KCNQ</styled-content>1 and <styled-content style="fixed-case">KCNJ</styled-content>2 were increased 1.4±0.4‐fold (<italic>P</italic>=0.040) and 2.1±1.4‐fold (<italic>P</italic>=0.046) in the moderate <styled-content style="fixed-case">OSA</styled-content> group. Compared with patients with mild or moderate <styled-content style="fixed-case">OSA</styled-content>, patients with severe <styled-content style="fixed-case">OSA</styled-content> had a persistently higher apnea–hypopnea index (mild 2.0±1.8, moderate 1.0±0.9, severe 5.8±5.6; <italic>P</italic>=0.015), perhaps explaining why the potassium channel changes were not seen in the severe <styled-content style="fixed-case">OSA</styled-content> group.</p>
                </sec>
                <sec id="jah31645-sec-0003">
                  <title>Conclusions</title>
                  <p>The <styled-content style="fixed-case">mRNA</styled-content> expression of most potassium channels inversely correlates with the severity of <styled-content style="fixed-case">OSA</styled-content> and hypoxemia. Continuous positive airway pressure therapy improves circulating <styled-content style="fixed-case">KCNQ</styled-content>1 and <styled-content style="fixed-case">KCNJ</styled-content>2 in patients with moderate <styled-content style="fixed-case">OSA</styled-content>.</p>
                </sec>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="jah31645-kwd-0001">arrhythmia</kwd>
                <kwd id="jah31645-kwd-0002">gene regulation</kwd>
                <kwd id="jah31645-kwd-0003">hypoxia</kwd>
                <kwd id="jah31645-kwd-0004">ion channel</kwd>
                <kwd id="jah31645-kwd-0005">potassium‐channel</kwd>
                <kwd id="jah31645-kwd-0006">sleep apnea</kwd>
              </kwd-group>
              <kwd-group kwd-group-type="subject-categories">
                <title>Subject Categories</title>
                <kwd>Arrhythmias</kwd>
                <kwd>Ion Channels/Membrane Transport</kwd>
                <kwd>Gene Expression &amp; Regulation</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>National Institutes of Health</funding-source>
                  <award-id>R01 HL104025</award-id>
                  <award-id>HL106592</award-id>
                </award-group>
              </funding-group>
              <counts>
                <page-count count="7"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>component-id</meta-name>
                  <meta-value>jah31645</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>August 2016</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.4 mode:remove_FC converted:24.08.2016</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="jah31645-cit-1001">(<source>J Am Heart Assoc</source>. <year>2016</year>;<volume>5</volume>:e003666 doi: <ext-link ext-link-type="doi" xlink:href="10.1161/JAHA.116.003666">10.1161/JAHA.116.003666</ext-link>)</mixed-citation>
              </p>
            </notes>
          </front>
          <body>
            <sec id="jah31645-sec-0004">
              <title>Introduction</title>
              <p>Obstructive sleep apnea (OSA) is a highly prevalent and underdiagnosed disease.<xref rid="jah31645-bib-0001" ref-type="ref">1</xref> A recent large clinical trial established OSA as a novel risk factor for sudden cardiac death (SCD).<xref rid="jah31645-bib-0002" ref-type="ref">2</xref> After 20 years of follow‐up, the Busselton health study cohort showed that moderate to severe sleep apnea was independently associated with an increased risk of all‐cause mortality.<xref rid="jah31645-bib-0003" ref-type="ref">3</xref> In a longitudinal study of 10 701 adults, OSA was associated with SCD, and the magnitude of risk varied with OSA severity.<xref rid="jah31645-bib-0002" ref-type="ref">2</xref>
</p>
              <p>QT prolongation is an independent risk factor for SCD,<xref rid="jah31645-bib-0004" ref-type="ref">4</xref>, <xref rid="jah31645-bib-0005" ref-type="ref">5</xref>, <xref rid="jah31645-bib-0006" ref-type="ref">6</xref> and OSA is associated with longer QT intervals.<xref rid="jah31645-bib-0007" ref-type="ref">7</xref>, <xref rid="jah31645-bib-0008" ref-type="ref">8</xref> This electrocardiographic effect is thought to be caused by systemic hypoxia, hypercarbia, or acidosis. The most effective treatment for OSA is continuous positive airway pressure (CPAP) therapy, which improves oxygenation and decreases sleep fragmentation. CPAP improves prolonged cardiac repolarization<xref rid="jah31645-bib-0009" ref-type="ref">9</xref> and decreases the rate of death.<xref rid="jah31645-bib-0010" ref-type="ref">10</xref> CPAP withdrawal is associated with prolongation of the corrected QT interval.<xref rid="jah31645-bib-0011" ref-type="ref">11</xref>
</p>
              <p>The genetic link of SCD and QT interval to potassium channels has been well established in inherited long QT syndromes.<xref rid="jah31645-bib-0012" ref-type="ref">12</xref> Loss‐of‐function gene mutations of cardiac potassium channels contribute to different types of long QT syndromes, such as KCNQ1 (long QT syndrome type 1 [LQT1]), KCNH2 (LQT2), KCNE1 (LQT5), KCNE2 (LQT6), and KCNJ2 (LQT7).<xref rid="jah31645-bib-0013" ref-type="ref">13</xref>, <xref rid="jah31645-bib-0014" ref-type="ref">14</xref> Other potassium channels expressed in the heart include KCND3, encoding the potassium channel that underlies the transient outward current Ito<xref rid="jah31645-bib-0015" ref-type="ref">15</xref>; KCNA5, encoding the potassium channel that underlies I<sub>Kur</sub>
<xref rid="jah31645-bib-0016" ref-type="ref">16</xref>; and KCNJ11, encoding Kir6.2, which underlies the inward rectifying channel.<xref rid="jah31645-bib-0017" ref-type="ref">17</xref>
</p>
              <p>In summary, OSA is associated with QT prolongation and SCD. CPAP improves QT prolongation.<xref rid="jah31645-bib-0009" ref-type="ref">9</xref>, <xref rid="jah31645-bib-0011" ref-type="ref">11</xref> QT interval is influenced by potassium channels. In our previously published study, the levels of circulating cardiac sodium channel full‐length mRNA and splicing variants in white blood cells were representative of levels in the myocardium.<xref rid="jah31645-bib-0018" ref-type="ref">18</xref> Based on these observations, we reasoned that circulating white blood cells may experience conditions similar to those of cardiomyocytes and may reveal insights into the mechanism of QT changes with OSA and CPAP. We hypothesized that prolonged QT in OSA represented altered potassium channel regulation and that this regulation would be reflected in circulating white blood cells.</p>
            </sec>
            <sec id="jah31645-sec-0005">
              <title>Materials and Methods</title>
              <sec id="jah31645-sec-0006">
                <title>Clinical Characteristics of the OSA Population and Inclusion Criteria</title>
                <p>This study was a multicenter prospective clinical trial entitled “Sodium Channel Splicing in Obstructive Sleep Apnea (SOCS‐OSA)” and was conducted at the Lifespan Health System (Rhode Island Hospital and the Miriam Hospital) in Providence, Rhode Island, and at the University of Illinois at Chicago (UIC) in Chicago, Illinois. The study was approved by the Lifespan and UIC institutional review boards. All study participants signed written informed consent before enrollment. Participants were enrolled from July, 2014 to November, 2015. This study was preparatory for the study listed in <ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov">ClinicalTrials.gov</ext-link> with identifier NCT02725632.</p>
                <p>Participants were adults (aged ≥18 years) with OSA newly diagnosed by polysomnogram who agreed to CPAP treatment (OSA group) or adults without OSA (control group). All trial participants were screened with the STOP‐Bang Questionnaire<xref rid="jah31645-bib-0019" ref-type="ref">19</xref> before proceeding to the sleep study. The diagnosis of OSA was confirmed by an overnight sleep study. Based on the severity of apnea–hypopnea index (AHI), OSA patients were assigned to 3 groups: mild (AHI 5–15), moderate (AHI 15–30), or severe (AHI &gt;30).<xref rid="jah31645-bib-0020" ref-type="ref">20</xref> The AHI was defined as the number of apneas and hypopneas per hour and calculated by adding the total number of apnea and hypopnea events and dividing by the total number of minutes of actual sleep time multiplied by 60. Control participants were those with AHI &lt;5 by polysomnogram.</p>
                <p>The overnight sleep study consisted of continuous polygraphic recordings from 10 <sc>pm</sc> to 7 <sc>am</sc>, and the baseline parameters were measured. Arterial oxygen saturation was recorded by digital pulse oximeter, and the nadir arterial oxygen saturation levels (nadir O<sub>2</sub>) were obtained. The oxygen desaturation index is the number of times per hour of sleep that the blood's oxygen level drops by ≥3% or ≥4% (ie, ODI4) from baseline. To quantify overall nocturnal desaturation, we used the cumulative percentages of sleep time spent at saturations &lt;90% or &lt;85%. Respiratory disturbance index was defined as the average number of episodes of apnea, hypopnea, and respiratory event–related arousals per hour of sleep documented in the polysomnography.</p>
                <p>After 4 weeks of CPAP therapy, an AHI score was measured and documented as residual AHI, which was used to assess the efficacy of CPAP therapy.</p>
                <p>The OSA patients were evaluated with the Epworth Sleepiness Scale (ESS)<xref rid="jah31645-bib-0021" ref-type="ref">21</xref> and the Functional Outcome of Sleep Questionnaire 10 (FOSQ‐10)<xref rid="jah31645-bib-0022" ref-type="ref">22</xref> at the time of initial diagnosis. CPAP compliance data were collected from the CPAP machine in the pulmonary clinic. Improvement of the symptoms were reevaluated by the ESS and FOSQ‐10 after 1 month of CPAP treatment.</p>
                <p>The exclusion criteria included chronic use of hypnotics; current drug or alcohol addiction; a rhythm other than sinus at enrollment; mandatory and biventricular pacing; a history of heart transplant or left ventricular assist device; active use of intravenous vasodilators, vasopressors, or inotropes; hemodialysis or peritoneal dialysis; active infection; acute coronary syndrome; major trauma or surgery; malignant neoplastic disease on active treatment including chemotherapy and radiation therapy; life expectancy &lt;1 year; collagen vascular disease on active treatment including steroids and other immunomodulating drugs; systemic steroid use; or concomitant use of an investigational drug.</p>
              </sec>
              <sec id="jah31645-sec-0007">
                <title>Sample Collection and Processing</title>
                <p>Blood samples were collected in PAXgene blood RNA tubes (Qiagen) and were stored in a freezer at −80°C before processing. Total RNA was isolated with the use of the PAXgene blood RNA isolation kit and was then converted to cDNA with the use of the SuperScript III cDNA Reverse Transcription Kit (Life Technologies). Only samples with an optical density of 260/280&gt;2.0 and 260/230&gt;1.7 were used. Repeated measures of the same sample varied by &lt;2%. Quantitative reverse transcriptase polymerase chain reaction was performed to detect the abundance of potassium channels using iQSYBR Green Supermix (Bio‐Rad Laboratories) and the 7500 Fast Real‐Time PCR System (Life Technologies). The primer sequences used were HKCNQ1F (5′‐TTGGGAAGCCCTCACTGTTC‐3′), HKCNQ1R (5′‐CTGGTG AAGCATGTCGGTGA‐3′), HKCNH2F (5′‐TCACCGCCCTGTACTTCATCT‐3′), HKCNH2R (5′‐CAGGCCTTGCATACA GGTTCA‐3′), HKCNE1F (5′‐GAACCCCACCACTGGCTAAA‐3′), HKCNE1R (5′‐TAATCCA CCCCTCACCCCTT‐3′), HKCNE2F (5′‐ATTTCATCCTGCCCACACACT‐3′), HKCNE2R (5′‐ CCAGCGTCTGTGTGAAATTGG‐3′), HKCNA5F (5′‐AGAGGAGTCCAGCGGAAGGT‐3′), HKCNA5R (5′‐ACTGTCTGCATTCTCCAGGGT‐3′), HKCNJ11F (5′‐TCCAGGGTGTTACAA GGCAC‐3′), HKCNJ11R (5′‐GAATTGGGTTGGGAGGAGCA‐3′), HKCNJ2F (5′‐TGTCACGG ATGAATGCCCAA‐3′), HKCNJ2R (5′‐CTGCGCCAATGATGAAAGCA‐3′), HKCND3F (5′‐T GTACGAACCTCCACCATCAA‐3′), and HKCND3R (5′‐ATGGGTAGTTCTGCATTGAACT CT‐3′). Quantitative reverse transcriptase polymerase chain reaction thermal cycling conditions were initial incubation at 50°C for 60 minutes and then termination of the reactions at 85°C for 5 minutes. Polymerase chain reaction was performed with an initial denaturation step at 95°C for 20 seconds, followed by 40 cycles of denaturation at 95°C for 3 seconds and annealing and nucleotide prolongation at 60°C for 30 seconds. Each sample was measured for the target genes <italic>KCNQ1, KCNH2, KCNE1, KCNE2, KCNA5, KCNJ11, KCNJ2, KCND3</italic>, and β‐actin. Samples were normalized to the level of β‐actin.</p>
              </sec>
              <sec id="jah31645-sec-0008">
                <title>Statistical Analysis</title>
                <p>Data were analyzed using SPSS for Windows (IBM Corp). Continuous variables were described in terms of descriptive statistics (mean and standard deviation). Categorical variables are expressed in terms of frequencies and percentages. Independent samples <italic>t</italic> tests and Pearson chi‐square tests were used for bivariate analysis comparisons of continuous and categorical variables, respectively. The Pearson correlation coefficient was used to assess the correlation between the parameters measured in the sleep study, the severity of OSA, and the mRNA levels of potassium channels. Differences between gene expression at baseline and at the follow‐up visit were examined by means of paired Wilcoxon tests. Differences in gene expression among the groups were examined by the Kruskal–Wallis ANOVA or the Mann–Whitney <italic>U</italic> tests. For all analyses, a <italic>P</italic>&lt;0.05 was considered statistically significant.</p>
              </sec>
            </sec>
            <sec id="jah31645-sec-0009">
              <title>Results</title>
              <sec id="jah31645-sec-0010">
                <title>Demographic and Clinical Characteristics</title>
                <p>Overall, 28 OSA patients and 6 participants without OSA met eligibility criteria and completed the baseline and follow‐up visits. The mean age (±SD) was 50.7±10.1 years in OSA patients and 43.6±16.3 years in participants without OSA. The baseline body mass index was 36.4±8.1 in OSA patients and 39.5±10.7 in participants without OSA. At baseline, there was no significant difference in demographic characteristics between groups (Table <xref rid="jah31645-tbl-0001" ref-type="table-wrap">1</xref>).</p>
                <table-wrap id="jah31645-tbl-0001" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 1</label>
                  <caption>
                    <p>Clinical Characteristics of the SOCS‐OSA Study</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1"/>
                        <th align="left" valign="top" rowspan="1" colspan="1">No OSA (n=6)</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">Mild OSA (n=10)</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">Moderate OSA (n=6)</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">Severe OSA (n=12)</th>
                        <th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic> Value<xref ref-type="fn" rid="jah31645-note-0002">a</xref>
</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age</td>
                        <td align="left" rowspan="1" colspan="1">43.6±16.6</td>
                        <td align="left" rowspan="1" colspan="1">53.1±7.4</td>
                        <td align="left" rowspan="1" colspan="1">51.3±11.3</td>
                        <td align="left" rowspan="1" colspan="1">48.1±12.2</td>
                        <td align="left" rowspan="1" colspan="1">0.418</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">BMI</td>
                        <td align="left" rowspan="1" colspan="1">39.5±9.7</td>
                        <td align="left" rowspan="1" colspan="1">35.6±8.0</td>
                        <td align="left" rowspan="1" colspan="1">37.5±7.6</td>
                        <td align="left" rowspan="1" colspan="1">36.6±10.6</td>
                        <td align="left" rowspan="1" colspan="1">0.776</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">STOP‐Bang</td>
                        <td align="left" rowspan="1" colspan="1">5.4±0.9</td>
                        <td align="left" rowspan="1" colspan="1">4.1±1.4</td>
                        <td align="left" rowspan="1" colspan="1">5.6±1.3</td>
                        <td align="left" rowspan="1" colspan="1">5.6±1.1</td>
                        <td align="left" rowspan="1" colspan="1">0.022</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">AHI</td>
                        <td align="left" rowspan="1" colspan="1">3.5±1.6</td>
                        <td align="left" rowspan="1" colspan="1">9.5±2.9</td>
                        <td align="left" rowspan="1" colspan="1">20.2±1.6</td>
                        <td align="left" rowspan="1" colspan="1">65.6±40.3</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">RDI</td>
                        <td align="left" rowspan="1" colspan="1">6.0±3.3</td>
                        <td align="left" rowspan="1" colspan="1">15.5±5.0</td>
                        <td align="left" rowspan="1" colspan="1">26.6±5.1</td>
                        <td align="left" rowspan="1" colspan="1">45.5±13.8</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">ODI4</td>
                        <td align="left" rowspan="1" colspan="1">3.1±1.7</td>
                        <td align="left" rowspan="1" colspan="1">8.5±4.1</td>
                        <td align="left" rowspan="1" colspan="1">19.3±5.4</td>
                        <td align="left" rowspan="1" colspan="1">32.7±16.6</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">ODI3</td>
                        <td align="left" rowspan="1" colspan="1">6.3±2.1</td>
                        <td align="left" rowspan="1" colspan="1">13.7±5.8</td>
                        <td align="left" rowspan="1" colspan="1">28.9±6.4</td>
                        <td align="left" rowspan="1" colspan="1">40.6±18.4</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Nadir oxygen saturation</td>
                        <td align="left" rowspan="1" colspan="1">86.8±5.0</td>
                        <td align="left" rowspan="1" colspan="1">83.7±4.1</td>
                        <td align="left" rowspan="1" colspan="1">84.4±3.7</td>
                        <td align="left" rowspan="1" colspan="1">74.2±16.0</td>
                        <td align="left" rowspan="1" colspan="1">0.139</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">CT<sub>90</sub>, minute</td>
                        <td align="left" rowspan="1" colspan="1">0.4±0.5</td>
                        <td align="left" rowspan="1" colspan="1">8.8±18.2</td>
                        <td align="left" rowspan="1" colspan="1">7.7±10.5</td>
                        <td align="left" rowspan="1" colspan="1">34.0±63.9</td>
                        <td align="left" rowspan="1" colspan="1">0.016</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">CT<sub>85</sub>, minute</td>
                        <td align="left" rowspan="1" colspan="1">0±0.1</td>
                        <td align="left" rowspan="1" colspan="1">0.4±0.7</td>
                        <td align="left" rowspan="1" colspan="1">0.4±1.0</td>
                        <td align="left" rowspan="1" colspan="1">19.3±47.2</td>
                        <td align="left" rowspan="1" colspan="1">0.077</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">CPAP average use, hours/night</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">4.8±1.3</td>
                        <td align="left" rowspan="1" colspan="1">4.0±2.5</td>
                        <td align="left" rowspan="1" colspan="1">4.1±1.9</td>
                        <td align="left" rowspan="1" colspan="1">0.849</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Residual AHI</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">2.0±1.8</td>
                        <td align="left" rowspan="1" colspan="1">1.0±0.9</td>
                        <td align="left" rowspan="1" colspan="1">5.8±5.6</td>
                        <td align="left" rowspan="1" colspan="1">0.015</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">CPAP median use, hours/night</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">5.5±0.8</td>
                        <td align="left" rowspan="1" colspan="1">5.1±3.7</td>
                        <td align="left" rowspan="1" colspan="1">4.0±1.5</td>
                        <td align="left" rowspan="1" colspan="1">0.171</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="jah31645-note-0001">
                      <p>AHI indicates apnea–hypopnea index; BMI, body mass index; CPAP, continuous positive airway pressure; CT<sub>85</sub>, the cumulative percentages of sleep time spent at saturations &lt;85%; CT<sub>90</sub>, the cumulative percentages of sleep time spent at saturations &lt;90%; ODI3, the number of times per hour of sleep that the blood's oxygen level drops by ≥3% from baseline; ODI4, the number of times per hour of sleep that the blood's oxygen level drops by ≥4% from baseline; OSA, obstructive sleep apnea; RDI, respiratory disturbance index; residual AHI, the apnea–hypopnea index after 4 weeks of continuous positive airway pressure therapy.</p>
                    </fn>
                    <fn id="jah31645-note-0002">
                      <label>a</label>
                      <p><italic>P</italic> value from <italic>t</italic> tests for continuous variables and chi‐square tests for categorical variables. Data are expressed as mean±SD.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>The sleep characteristics and CPAP treatment among participants with OSA are shown in Table <xref rid="jah31645-tbl-0001" ref-type="table-wrap">1</xref>. As expected, CPAP therapy was associated with significant reductions in AHI. Nevertheless, compared with patients with mild or moderate OSA, patients with severe OSA had significantly higher residual AHI (mild 2.0±1.8, moderate 1.0±0.9, severe 5.8±5.6; <italic>P</italic>=0.015).</p>
              </sec>
              <sec id="jah31645-sec-0011">
                <title>Comparison of the Questionnaires Among OSA Groups</title>
                <p>The STOP‐Bang questionnaire was used to screen for OSA. Compared with patients with mild OSA, patients with moderate OSA had markedly higher scores (mild 4.1±1.4, moderate 6.0±1.3, severe 5.4±1.1; <italic>P</italic>=0.022). There was no statistically significant difference between moderate and severe OSA, and that might be explained by use of the STOP‐Bang questionnaire, which is highly sensitive at low scores and highly specific at high scores for OSA.<xref rid="jah31645-bib-0023" ref-type="ref">23</xref> The OSA patients were evaluated with the ESS questionnaire to measure daytime sleepiness before and after CPAP therapy. The ESS score significantly decreased after 4 weeks of CPAP in mild and moderate OSA patients (mild 12.6±5.2 versus 9.2±6.1, <italic>P</italic>=0.028; moderate 11.7±4.5 versus 7.3±5.7, <italic>P</italic>=0.034; severe 12.3±6.6 versus 10.7±5.3, <italic>P</italic>=0.497).</p>
              </sec>
              <sec id="jah31645-sec-0012">
                <title>Baseline Potassium Channel mRNA Expression Correlated With the Severity of OSA</title>
                <p>We observed a significant inverse correlation between the severity of OSA stratified by AHI and the mRNA expression of the main potassium channels assessed: KCNQ1 (<italic>r</italic>=−0.486, <italic>P</italic>=0.007), KCNH2 (<italic>r</italic>=−0.437, <italic>P</italic>=0.016), KCNE1 (<italic>r</italic>=−0.567, <italic>P</italic>=0.001), KCNJ2 (<italic>r</italic>=−0.442, <italic>P</italic>=0.015), and KCNA5 (<italic>r</italic>=−0.468, <italic>P</italic>=0.009) (Figure <xref rid="jah31645-fig-0001" ref-type="fig">1</xref> and Table <xref rid="jah31645-tbl-0002" ref-type="table-wrap">2</xref>). In addition, KCNQ1 (<italic>r</italic>=−0.404, <italic>P</italic>=0.027), KCNH2 (<italic>r</italic>=−0.416, <italic>P</italic>=0.022), and KCNE1 (<italic>r</italic>=−0.465, <italic>P</italic>=0.010) inversely correlated with ODI4, indicating the oxygen desaturation status (Figure <xref rid="jah31645-fig-0002" ref-type="fig">2</xref> and Table <xref rid="jah31645-tbl-0002" ref-type="table-wrap">2</xref>).</p>
                <fig fig-type="Figure" xml:lang="en" id="jah31645-fig-0001" orientation="portrait" position="float">
                  <label>Figure 1</label>
                  <caption>
                    <p>Baseline potassium channel <styled-content style="fixed-case">mRNA</styled-content> expression correlated with <styled-content style="fixed-case">AHI</styled-content>. A, Correlation between <styled-content style="fixed-case">mRNA</styled-content> level of <styled-content style="fixed-case">KCNQ</styled-content>1 (ordinate) and AHI (abscissa). <italic>r</italic>=−0.48, <italic>P</italic>&lt;0.01. B, Correlation between <styled-content style="fixed-case">mRNA</styled-content> level of <styled-content style="fixed-case">KCNJ</styled-content>2 (ordinate) and AHI (abscissa). <italic>r</italic>=−0.47, <italic>P</italic>&lt;0.01. AHI indicates apnea–hypopnea index.</p>
                  </caption>
                  <graphic id="nlm-graphic-1" xlink:href="JAH3-5-e003666-g001"/>
                </fig>
                <table-wrap id="jah31645-tbl-0002" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 2</label>
                  <caption>
                    <p>Correlation of the Expression of Baseline Potassium Channels With Hypoxia</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1"/>
                        <th align="left" valign="top" rowspan="1" colspan="1">KCNQ1</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">KCNH2</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">KCNE1</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">KCNE2</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">KCNJ2</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">KCNA5</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">KCNJ11</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">KCND3</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">Log<sub>10</sub>AHI</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">
                          <italic>r</italic>
                        </td>
                        <td align="left" rowspan="1" colspan="1">−0.486</td>
                        <td align="left" rowspan="1" colspan="1">−0.437</td>
                        <td align="left" rowspan="1" colspan="1">−0.567</td>
                        <td align="left" rowspan="1" colspan="1">0.002</td>
                        <td align="left" rowspan="1" colspan="1">−0.442</td>
                        <td align="left" rowspan="1" colspan="1">−0.468</td>
                        <td align="left" rowspan="1" colspan="1">−0.329</td>
                        <td align="left" rowspan="1" colspan="1">−0.249</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1"><italic>P</italic> value</td>
                        <td align="left" rowspan="1" colspan="1">0.007</td>
                        <td align="left" rowspan="1" colspan="1">0.016</td>
                        <td align="left" rowspan="1" colspan="1">0.001</td>
                        <td align="left" rowspan="1" colspan="1">0.993</td>
                        <td align="left" rowspan="1" colspan="1">0.015</td>
                        <td align="left" rowspan="1" colspan="1">0.009</td>
                        <td align="left" rowspan="1" colspan="1">0.076</td>
                        <td align="left" rowspan="1" colspan="1">0.184</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">Log<sub>10</sub>ODI4</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">
                          <italic>r</italic>
                        </td>
                        <td align="left" rowspan="1" colspan="1">−0.404</td>
                        <td align="left" rowspan="1" colspan="1">−0.416</td>
                        <td align="left" rowspan="1" colspan="1">−0.465</td>
                        <td align="left" rowspan="1" colspan="1">−0.021</td>
                        <td align="left" rowspan="1" colspan="1">−0.349</td>
                        <td align="left" rowspan="1" colspan="1">−0.326</td>
                        <td align="left" rowspan="1" colspan="1">−0.296</td>
                        <td align="left" rowspan="1" colspan="1">−0.285</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1"><italic>P</italic> value</td>
                        <td align="left" rowspan="1" colspan="1">0.027</td>
                        <td align="left" rowspan="1" colspan="1">0.022</td>
                        <td align="left" rowspan="1" colspan="1">0.010</td>
                        <td align="left" rowspan="1" colspan="1">0.912</td>
                        <td align="left" rowspan="1" colspan="1">0.059</td>
                        <td align="left" rowspan="1" colspan="1">0.079</td>
                        <td align="left" rowspan="1" colspan="1">0.112</td>
                        <td align="left" rowspan="1" colspan="1">0.127</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">Nadir O<sub>2</sub>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">
                          <italic>r</italic>
                        </td>
                        <td align="left" rowspan="1" colspan="1">0.268</td>
                        <td align="left" rowspan="1" colspan="1">0.269</td>
                        <td align="left" rowspan="1" colspan="1">0.344</td>
                        <td align="left" rowspan="1" colspan="1">0.180</td>
                        <td align="left" rowspan="1" colspan="1">0.268</td>
                        <td align="left" rowspan="1" colspan="1">0.146</td>
                        <td align="left" rowspan="1" colspan="1">0.020</td>
                        <td align="left" rowspan="1" colspan="1">0.370</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1"><italic>P</italic> value</td>
                        <td align="left" rowspan="1" colspan="1">0.153</td>
                        <td align="left" rowspan="1" colspan="1">0.150</td>
                        <td align="left" rowspan="1" colspan="1">0.063</td>
                        <td align="left" rowspan="1" colspan="1">0.349</td>
                        <td align="left" rowspan="1" colspan="1">0.152</td>
                        <td align="left" rowspan="1" colspan="1">0.440</td>
                        <td align="left" rowspan="1" colspan="1">0.915</td>
                        <td align="left" rowspan="1" colspan="1">0.044</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="jah31645-note-0003">
                      <p>AHI indicates apnea–hypopnea index; nadir O<sub>2</sub>, nadir arterial oxygen saturation levels; ODI4, the number of times per hour of sleep that the blood's oxygen level drops by ≥4% from baseline.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <fig fig-type="Figure" xml:lang="en" id="jah31645-fig-0002" orientation="portrait" position="float">
                  <label>Figure 2</label>
                  <caption>
                    <p>Baseline potassium channel <styled-content style="fixed-case">mRNA</styled-content> expression correlated with <styled-content style="fixed-case">ODI</styled-content>4. A, Correlation between <styled-content style="fixed-case">mRNA</styled-content> level of <styled-content style="fixed-case">KCNQ</styled-content>1 (ordinate) and <styled-content style="fixed-case">ODI</styled-content>4 (abscissa). <italic>r</italic>=−0.45, <italic>P</italic>&lt;0.05. B, Correlation between <styled-content style="fixed-case">mRNA</styled-content> level of <styled-content style="fixed-case">KCNJ</styled-content>2 (ordinate) and <styled-content style="fixed-case">ODI</styled-content>4 (abscissa). <italic>r</italic>=−0.41, <italic>P</italic>&lt;0.05. <styled-content style="fixed-case">ODI</styled-content>4 indicates the number of times per hour of sleep that the blood's oxygen level drops by ≥4% from baseline.</p>
                  </caption>
                  <graphic id="nlm-graphic-3" xlink:href="JAH3-5-e003666-g002"/>
                </fig>
              </sec>
              <sec id="jah31645-sec-0013">
                <title>CPAP Improved Circulating KCNQ1 and KCNJ2 in Moderate OSA Patients</title>
                <p>For patients with newly diagnosed OSA initiating CPAP for the first time, circulating KCNQ1 and KCNJ2 were increased 1.4±0.4‐fold (<italic>P</italic>=0.040) and 2.1±1.4‐fold (<italic>P</italic>=0.046), respectively, after 4 weeks of CPAP therapy in the moderate group (Figure <xref rid="jah31645-fig-0003" ref-type="fig">3</xref>). Although they did not reach statistical significance, CPAP improved most potassium channel gene expression in moderate OSA: KCNE1 1.5‐fold, KCNE2 2.9‐fold, KCNA5 1.9‐fold, KCND3 1.3‐fold, and KCNJ11 1.6‐fold.</p>
                <fig fig-type="Figure" xml:lang="en" id="jah31645-fig-0003" orientation="portrait" position="float">
                  <label>Figure 3</label>
                  <caption>
                    <p><styled-content style="fixed-case">CPAP</styled-content> improves <styled-content style="fixed-case">KCNQ</styled-content>1 and <styled-content style="fixed-case">KCNJ</styled-content>2 in patients with moderate <styled-content style="fixed-case">OSA</styled-content>. *<italic>P</italic>&lt;0.05 comparing the post‐<styled-content style="fixed-case">CPAP</styled-content> fold change of <styled-content style="fixed-case">KCNQ</styled-content>1 or <styled-content style="fixed-case">KCNJ</styled-content>2 to the baseline in the moderate <styled-content style="fixed-case">OSA</styled-content> group. CPAP indicates continuous positive airway pressure; OSA, obstructive sleep apnea.</p>
                  </caption>
                  <graphic id="nlm-graphic-5" xlink:href="JAH3-5-e003666-g003"/>
                </fig>
              </sec>
            </sec>
            <sec id="jah31645-sec-0014">
              <title>Discussion</title>
              <p>The main findings of this prospective study are that the mRNA expression of at least 5 of 8 cardiac potassium channels correlated with the severity of OSA and that CPAP treatment improved circulating KCNQ1 and KCNJ2 in patients with moderate OSA. There were trends toward increases in 7 of 8 potassium channels in patients with moderate OSA.</p>
              <p>QT prolongation is an independent risk factor for SCD. In the Oregon Sudden Unexpected Death Study, idiopathic abnormal prolongation of the corrected QT interval was associated with 5‐fold increased odds of SCD.<xref rid="jah31645-bib-0005" ref-type="ref">5</xref> Recent genetic studies have established a clear inverse relationship between QT interval and expression and function of potassium channels. Gene defects resulting in loss of function of voltage‐gated potassium channels, for example, are associated with long QT syndromes: LQT1 (KCNQ1) and LQT2 (KCNH2), encoding α‐subunits of the potassium channels I<sub>Ks</sub> and I<sub>Kr</sub>; LQT5 (KCNE1) and LQT6 (KCNE2), encoding β‐subunits of the potassium channels I<sub>Ks</sub> and I<sub>Kr</sub>; and LQT7 (KCNJ2), encoding the inward rectifier potassium channel Kir2.1.<xref rid="jah31645-bib-0012" ref-type="ref">12</xref>, <xref rid="jah31645-bib-0013" ref-type="ref">13</xref>, <xref rid="jah31645-bib-0014" ref-type="ref">14</xref>, <xref rid="jah31645-bib-0015" ref-type="ref">15</xref>, <xref rid="jah31645-bib-0016" ref-type="ref">16</xref>, <xref rid="jah31645-bib-0017" ref-type="ref">17</xref>
</p>
              <p>OSA is associated with SCD and long QT. OSA predicted incident SCD in a longitudinal study of 10 701 adults.<xref rid="jah31645-bib-0003" ref-type="ref">3</xref> In OSA patients who had no evidence of underlying cardiac, pulmonary, or central nervous system disease, the QT interval was prolonged at the onset of apnea.<xref rid="jah31645-bib-0007" ref-type="ref">7</xref>
</p>
              <p>Because OSA is associated with long QT, and long QT can be caused by potassium channel loss of function, we tested whether OSA was associated with circulating potassium channel changes. A total of 8 potassium channel genes were studied, and we found that the mRNA levels of at least 5 of 8 potassium channel genes assessed correlated inversely with hypoxemia and OSA severity. Of these channel genes, 2 were statistically significantly increased and 5 more showed trends toward an increase with CPAP therapy. These results suggest that hypoxemia may be mediating these changes.</p>
              <p>KCNQ1 and KCNJ2 were improved with CPAP but only in the moderate OSA group. This could be explained if correction of hypoxia were the major driver for improvements in channel levels. Consistent with this idea, in a population of 10 701 adults, the magnitude of SCD risk was predicted by AHI and nocturnal oxygen desaturation.<xref rid="jah31645-bib-0003" ref-type="ref">3</xref> In our study, even with CPAP, severe OSA patients had higher residual AHI with statistical difference, and there was no change in potassium channel levels with CPAP. This supports the idea that the degree of hypoxia, rather than some other aspect of CPAP, was mediating the changes in mRNA abundance. In our patients with mild OSA, hypoxia was not severe and changed little with CPAP. This may explain why CPAP did not alter channel expression levels in this group.</p>
              <p>The transcription factor hypoxia‐inducible factor 1 (HIF‐1) plays a key role in cellular response to systemic oxygen levels in humans. HIF‐1α is a subunit of a heterodimeric HIF‐1.<xref rid="jah31645-bib-0024" ref-type="ref">24</xref>, <xref rid="jah31645-bib-0025" ref-type="ref">25</xref> There are 3 putative HIF‐1α transcription factor binding sites located in the upstream sequence of the human <italic>KCNQ1</italic> gene and 4 HIF‐1α binding sites located in the upstream sequence of the human <italic>KCNJ2</italic> gene (data not shown). The systemic oxygen level affects HIF‐1 through multiple mechanisms, such as HIF‐1α conformational changes and stability, subcellular localization, and transcriptional activity. HIF‐1 regulates the expression of &gt;60 genes involved in angiogenesis, cell proliferation, cell survival, and glucose and iron metabolism.<xref rid="jah31645-bib-0026" ref-type="ref">26</xref> The presence of HIF‐1α binding sites in the promoters of potassium channels may provide the mechanism by which systemic oxygen level affects the gene expression of potassium channels.</p>
              <p>This study has a number of limitations. Although the paired design controlled for interparticipant variability, the small sample size precluded comprehensive multivariable adjustment. In addition, because of the short study duration, it is not clear if the changes in potassium channel expression with CPAP will be durable or if they correlate with improved outcomes. Furthermore, we did not correlate potassium channel mRNA levels in white blood cells with levels or currents in the myocardium. Finally, electrocardiograms were not obtained from participants in this trial.</p>
            </sec>
            <sec id="jah31645-sec-0015">
              <title>Conclusions</title>
              <p>The mRNA expression of most potassium channels inversely correlated with the severity of OSA and hypoxemia. CPAP therapy improved circulating KCNQ1 and KCNJ2 mRNA levels in moderate OSA patients. If downregulations in circulating potassium channel genes with OSA are mirrored in the heart, as may happen if systemic hypoxemia is a causal factor, then downregulation of potassium channel genes in the heart may explain the long QT and increased risk of SCD in OSA. Moreover, it suggests that potassium channel gene levels may represent a new circulating marker for arrhythmic risk in OSA.</p>
            </sec>
            <sec id="jah31645-sec-0016">
              <title>Sources of Funding</title>
              <p>The present work was supported in part by National Institutes of Health grants R01 HL104025 and HL106592.</p>
            </sec>
            <sec id="jah31645-sec-0017">
              <title>Disclosures</title>
              <p>A provisional patent has been submitted based on this work.</p>
            </sec>
          </body>
          <back>
            <ref-list content-type="cited-references" id="jah31645-bibl-0001">
              <title>References</title>
              <ref id="jah31645-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0001"><string-name><surname>Punjabi</surname><given-names>NM</given-names></string-name>. <article-title>The epidemiology of adult obstructive sleep apnea</article-title>. <source>Proc Am Thorac Soc</source>. <year>2008</year>;<volume>5</volume>:<fpage>136</fpage>–<lpage>143</lpage>.<pub-id pub-id-type="pmid">18250205</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0002"><string-name><surname>Gami</surname><given-names>AS</given-names></string-name>, <string-name><surname>Olson</surname><given-names>EJ</given-names></string-name>, <string-name><surname>Shen</surname><given-names>WK</given-names></string-name>, <string-name><surname>Wright</surname><given-names>RS</given-names></string-name>, <string-name><surname>Ballman</surname><given-names>KV</given-names></string-name>, <string-name><surname>Hodge</surname><given-names>DO</given-names></string-name>, <string-name><surname>Herges</surname><given-names>RM</given-names></string-name>, <string-name><surname>Howard</surname><given-names>DE</given-names></string-name>, <string-name><surname>Somers</surname><given-names>VK</given-names></string-name>. <article-title>Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults</article-title>. <source>J Am Coll Cardiol</source>. <year>2013</year>;<volume>62</volume>:<fpage>610</fpage>–<lpage>616</lpage>.<pub-id pub-id-type="pmid">23770166</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0003"><string-name><surname>Marshall</surname><given-names>NS</given-names></string-name>, <string-name><surname>Wong</surname><given-names>KK</given-names></string-name>, <string-name><surname>Cullen</surname><given-names>SR</given-names></string-name>, <string-name><surname>Knuiman</surname><given-names>MW</given-names></string-name>, <string-name><surname>Grunstein</surname><given-names>RR</given-names></string-name>. <article-title>Sleep apnea and 20‐year followup for all‐cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study cohort</article-title>. <source>J Clin Sleep Med</source>. <year>2014</year>;<volume>10</volume>:<fpage>355</fpage>–<lpage>362</lpage>.<pub-id pub-id-type="pmid">24733978</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0004"><string-name><surname>Straus</surname><given-names>SM</given-names></string-name>, <string-name><surname>Kors</surname><given-names>JA</given-names></string-name>, <string-name><surname>De Bruin</surname><given-names>ML</given-names></string-name>, <string-name><surname>van der Hooft</surname><given-names>CS</given-names></string-name>, <string-name><surname>Hofman</surname><given-names>A</given-names></string-name>, <string-name><surname>Heeringa</surname><given-names>J</given-names></string-name>, <string-name><surname>Deckers</surname><given-names>JW</given-names></string-name>, <string-name><surname>Kingma</surname><given-names>JH</given-names></string-name>, <string-name><surname>Sturkenboom</surname><given-names>MC</given-names></string-name>, <string-name><surname>Stricker</surname><given-names>BH</given-names></string-name>, <string-name><surname>Witteman</surname><given-names>JC</given-names></string-name>. <article-title>Prolonged QTc interval and risk of sudden cardiac death in a population of older adults</article-title>. <source>J Am Coll Cardiol</source>. <year>2006</year>;<volume>47</volume>:<fpage>362</fpage>–<lpage>367</lpage>.<pub-id pub-id-type="pmid">16412861</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0005"><string-name><surname>Chugh</surname><given-names>SS</given-names></string-name>, <string-name><surname>Reinier</surname><given-names>K</given-names></string-name>, <string-name><surname>Singh</surname><given-names>T</given-names></string-name>, <string-name><surname>Uy‐Evanado</surname><given-names>A</given-names></string-name>, <string-name><surname>Socoteanu</surname><given-names>C</given-names></string-name>, <string-name><surname>Peters</surname><given-names>D</given-names></string-name>, <string-name><surname>Mariani</surname><given-names>R</given-names></string-name>, <string-name><surname>Gunson</surname><given-names>K</given-names></string-name>, <string-name><surname>Jui</surname><given-names>J</given-names></string-name>. <article-title>Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease. The Oregon Sudden Unexpected Death Study</article-title>. <source>Circulation</source>. <year>2009</year>;<volume>119</volume>:<fpage>663</fpage>–<lpage>670</lpage>.<pub-id pub-id-type="pmid">19171855</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0006"><string-name><surname>Algra</surname><given-names>A</given-names></string-name>, <string-name><surname>Tijssen</surname><given-names>JG</given-names></string-name>, <string-name><surname>Roelandt</surname><given-names>JR</given-names></string-name>, <string-name><surname>Pool</surname><given-names>J</given-names></string-name>, <string-name><surname>Lubsen</surname><given-names>J</given-names></string-name>. <article-title>QTc prolongation measured by standard 12‐lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest</article-title>. <source>Circulation</source>. <year>1991</year>;<volume>83</volume>:<fpage>1888</fpage>–<lpage>1894</lpage>.<pub-id pub-id-type="pmid">2040041</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0007"><string-name><surname>Gillis</surname><given-names>AM</given-names></string-name>, <string-name><surname>Stoohs</surname><given-names>R</given-names></string-name>, <string-name><surname>Guilleminault</surname><given-names>C</given-names></string-name>. <article-title>Changes in the QT interval during obstructive sleep apnea</article-title>. <source>Sleep</source>. <year>1991</year>;<volume>14</volume>:<fpage>346</fpage>–<lpage>350</lpage>.<pub-id pub-id-type="pmid">1947598</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0008"><string-name><surname>Camen</surname><given-names>G</given-names></string-name>, <string-name><surname>Clarenbach</surname><given-names>CF</given-names></string-name>, <string-name><surname>Stowhas</surname><given-names>AC</given-names></string-name>, <string-name><surname>Rossi</surname><given-names>VA</given-names></string-name>, <string-name><surname>Sievi</surname><given-names>NA</given-names></string-name>, <string-name><surname>Stradling</surname><given-names>JR</given-names></string-name>, <string-name><surname>Kohler</surname><given-names>M</given-names></string-name>. <article-title>The effects of simulated obstructive apnea and hypopnea on arrhythmic potential in healthy subjects</article-title>. <source>Eur J Appl Physiol</source>. <year>2013</year>;<volume>113</volume>:<fpage>489</fpage>–<lpage>496</lpage>.<pub-id pub-id-type="pmid">22806087</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0009"><string-name><surname>Roche</surname><given-names>F</given-names></string-name>, <string-name><surname>Barthelemy</surname><given-names>JC</given-names></string-name>, <string-name><surname>Garet</surname><given-names>M</given-names></string-name>, <string-name><surname>Duverney</surname><given-names>D</given-names></string-name>, <string-name><surname>Pichot</surname><given-names>V</given-names></string-name>, <string-name><surname>Sforza</surname><given-names>E</given-names></string-name>. <article-title>Continuous positive airway pressure treatment improves the QT rate dependence adaptation of obstructive sleep apnea patients</article-title>. <source>Pacing Clin Electrophysiol</source>. <year>2005</year>;<volume>28</volume>:<fpage>819</fpage>–<lpage>825</lpage>.<pub-id pub-id-type="pmid">16105010</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0010"><string-name><surname>Stanchina</surname><given-names>ML</given-names></string-name>, <string-name><surname>Welicky</surname><given-names>LM</given-names></string-name>, <string-name><surname>Donat</surname><given-names>W</given-names></string-name>, <string-name><surname>Lee</surname><given-names>D</given-names></string-name>, <string-name><surname>Corrao</surname><given-names>W</given-names></string-name>, <string-name><surname>Malhotra</surname><given-names>A</given-names></string-name>. <article-title>Impact of CPAP use and age on mortality in patients with combined COPD and obstructive sleep apnea: the overlap syndrome</article-title>. <source>J Clin Sleep Med</source>. <year>2013</year>;<volume>9</volume>:<fpage>767</fpage>–<lpage>772</lpage>.<pub-id pub-id-type="pmid">23946706</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0011"><string-name><surname>Rossi</surname><given-names>VA</given-names></string-name>, <string-name><surname>Stoewhas</surname><given-names>AC</given-names></string-name>, <string-name><surname>Camen</surname><given-names>G</given-names></string-name>, <string-name><surname>Steffel</surname><given-names>J</given-names></string-name>, <string-name><surname>Bloch</surname><given-names>KE</given-names></string-name>, <string-name><surname>Stradling</surname><given-names>JR</given-names></string-name>, <string-name><surname>Kohler</surname><given-names>M</given-names></string-name>. <article-title>The effects of continuous positive airway pressure therapy withdrawal on cardiac repolarization: data from a randomized controlled trial</article-title>. <source>Eur Heart J</source>. <year>2012</year>;<volume>33</volume>:<fpage>2206</fpage>–<lpage>2212</lpage>.<pub-id pub-id-type="pmid">22453648</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0012"><string-name><surname>Gutman</surname><given-names>GA</given-names></string-name>, <string-name><surname>Chandy</surname><given-names>KG</given-names></string-name>, <string-name><surname>Grissmer</surname><given-names>S</given-names></string-name>, <string-name><surname>Lazdunski</surname><given-names>M</given-names></string-name>, <string-name><surname>McKinnon</surname><given-names>D</given-names></string-name>, <string-name><surname>Pardo</surname><given-names>LA</given-names></string-name>, <string-name><surname>Robertson</surname><given-names>GA</given-names></string-name>, <string-name><surname>Rudy</surname><given-names>B</given-names></string-name>, <string-name><surname>Sanquinetti</surname><given-names>MC</given-names></string-name>, <string-name><surname>Stuhmer</surname><given-names>W</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X</given-names></string-name>. <article-title>International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage‐gated potassium channels</article-title>. <source>Pharmacol Rev</source>. <year>2005</year>;<volume>57</volume>:<fpage>473</fpage>–<lpage>508</lpage>.<pub-id pub-id-type="pmid">16382104</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0013"><string-name><surname>Splawski</surname><given-names>I</given-names></string-name>, <string-name><surname>Shen</surname><given-names>J</given-names></string-name>, <string-name><surname>Timothy</surname><given-names>KW</given-names></string-name>, <string-name><surname>Lehmann</surname><given-names>MH</given-names></string-name>, <string-name><surname>Priori</surname><given-names>S</given-names></string-name>, <string-name><surname>Robinson</surname><given-names>JL</given-names></string-name>, <string-name><surname>Moss</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Schwartz</surname><given-names>PJ</given-names></string-name>, <string-name><surname>Towbin</surname><given-names>JA</given-names></string-name>, <string-name><surname>Vincent</surname><given-names>GM</given-names></string-name>, <string-name><surname>Keating</surname><given-names>MT</given-names></string-name>. <article-title>Spectrum of mutations in long‐QT syndrome genes KVLQT1, HERG, SCN5A, KCNE1, and KCNE2</article-title>. <source>Circulation</source>. <year>2000</year>;<volume>102</volume>:<fpage>1178</fpage>–<lpage>1185</lpage>.<pub-id pub-id-type="pmid">10973849</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0014"><string-name><surname>Pongs</surname><given-names>O</given-names></string-name>, <string-name><surname>Leicher</surname><given-names>T</given-names></string-name>, <string-name><surname>Berger</surname><given-names>M</given-names></string-name>, <string-name><surname>Roeper</surname><given-names>J</given-names></string-name>, <string-name><surname>Bahring</surname><given-names>R</given-names></string-name>, <string-name><surname>Wray</surname><given-names>D</given-names></string-name>, <string-name><surname>Giese</surname><given-names>KP</given-names></string-name>, <string-name><surname>Silva</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Storm</surname><given-names>JF</given-names></string-name>. <article-title>Functional and molecular aspects of voltage gated K<sup>+</sup> channel beta subunits</article-title>. <source>Ann N Y Acad Sci</source>. <year>1999</year>;<volume>868</volume>:<fpage>344</fpage>–<lpage>355</lpage>.<pub-id pub-id-type="pmid">10414304</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0015"><string-name><surname>Raudebska</surname><given-names>M</given-names></string-name>, <string-name><surname>Bittnerova</surname><given-names>A</given-names></string-name>, <string-name><surname>Novotny</surname><given-names>T</given-names></string-name>, <string-name><surname>Florianova</surname><given-names>A</given-names></string-name>, <string-name><surname>Chroust</surname><given-names>K</given-names></string-name>, <string-name><surname>Gaillyova</surname><given-names>R</given-names></string-name>, <string-name><surname>Semrad</surname><given-names>B</given-names></string-name>, <string-name><surname>Kadlecova</surname><given-names>J</given-names></string-name>, <string-name><surname>Sisakova</surname><given-names>M</given-names></string-name>, <string-name><surname>Toman</surname><given-names>O</given-names></string-name>, <string-name><surname>Spinar</surname><given-names>J</given-names></string-name>. <article-title>Mutation analysis of candidate genes SCN1B, KCND3 and ANK2 in patients with clinical diagnosis of long QT syndrome</article-title>. <source>Physiol Res</source>. <year>2008</year>;<volume>57</volume>:<fpage>857</fpage>–<lpage>862</lpage>.<pub-id pub-id-type="pmid">18052691</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0016"><string-name><surname>Simard</surname><given-names>C</given-names></string-name>, <string-name><surname>Drolet</surname><given-names>B</given-names></string-name>, <string-name><surname>Yang</surname><given-names>P</given-names></string-name>, <string-name><surname>Kim</surname><given-names>RB</given-names></string-name>, <string-name><surname>Roden</surname><given-names>DM</given-names></string-name>. <article-title>Polymorphism screening in the cardiac K<sup>+</sup> channel gene KCNA5</article-title>. <source>Clin Pharmacol Ther</source>. <year>2005</year>;<volume>77</volume>:<fpage>138</fpage>–<lpage>144</lpage>.<pub-id pub-id-type="pmid">15735608</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0017"><string-name><surname>Hiraoka</surname><given-names>M</given-names></string-name>, <string-name><surname>Fan</surname><given-names>Z</given-names></string-name>. <article-title>Activation of ATP‐sensitive ourward K<sup>+</sup> current by nicorandil (2‐nicotinamideoethyl nitrate) in isolated ventricular myocytes</article-title>. <source>J Pharmacol Exp Ther</source>. <year>1989</year>;<volume>250</volume>:<fpage>278</fpage>–<lpage>285</lpage>.<pub-id pub-id-type="pmid">2526215</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0018"><string-name><surname>Gao</surname><given-names>G</given-names></string-name>, <string-name><surname>Brahmanandam</surname><given-names>V</given-names></string-name>, <string-name><surname>Raicu</surname><given-names>M</given-names></string-name>, <string-name><surname>Gu</surname><given-names>L</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>L</given-names></string-name>, <string-name><surname>Kasturirangan</surname><given-names>S</given-names></string-name>, <string-name><surname>Shah</surname><given-names>A</given-names></string-name>, <string-name><surname>Negi</surname><given-names>S</given-names></string-name>, <string-name><surname>Wood</surname><given-names>M</given-names></string-name>, <string-name><surname>Desai</surname><given-names>A</given-names></string-name>, <string-name><surname>Tatooles</surname><given-names>A</given-names></string-name>, <string-name><surname>Schwartz</surname><given-names>A</given-names></string-name>, <string-name><surname>Dudley</surname><given-names>S</given-names></string-name>. <article-title>Enhanced risk profiling of implanted defibrillator shocks with circulating SCN5A mRNA splicing variants: a pilot trial</article-title>. <source>J Am Coll Cardiol</source>. <year>2014</year>;<volume>63</volume>:<fpage>2261</fpage>–<lpage>2269</lpage>.<pub-id pub-id-type="pmid">24703920</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0019"><string-name><surname>Chung</surname><given-names>SA</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>H</given-names></string-name>, <string-name><surname>Chung</surname><given-names>F</given-names></string-name>. <article-title>A systemic review of obstructive sleep apnea and its implications for anesthesiologists</article-title>. <source>Anesth Analg</source>. <year>2008</year>;<volume>107</volume>:<fpage>1543</fpage>–<lpage>1563</lpage>.<pub-id pub-id-type="pmid">18931212</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0020"><article-title>Sleep‐related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force</article-title>. <source>Sleep</source>. <year>1999</year>;<volume>22</volume>:<fpage>667</fpage>–<lpage>689</lpage>.<pub-id pub-id-type="pmid">10450601</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0021"><string-name><surname>John</surname><given-names>HT</given-names></string-name>, <string-name><surname>Watson</surname><given-names>M</given-names></string-name>, <string-name><surname>Haines</surname><given-names>FJ</given-names></string-name>. <article-title>A new method for inducing hypothermia</article-title>. <source>Lancet</source>. <year>1967</year>;<volume>2</volume>:<fpage>1310</fpage>.<pub-id pub-id-type="pmid">4168636</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0022"><string-name><surname>Chasens</surname><given-names>ER</given-names></string-name>, <string-name><surname>Ratcliffe</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Weaver</surname><given-names>TE</given-names></string-name>. <article-title>Development of the FOSQ‐10: a short version of the Functional Outcomes of Sleep Questionnaire</article-title>. <source>Sleep</source>. <year>2009</year>;<volume>32</volume>:<fpage>915</fpage>–<lpage>919</lpage>.<pub-id pub-id-type="pmid">19639754</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0023"><string-name><surname>Chung</surname><given-names>F</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Liao</surname><given-names>P</given-names></string-name>. <article-title>Predictive performance of the STOP‐Bang score for identifying obstructive sleep apnea in obese patients</article-title>. <source>Obes Surg</source>. <year>2013</year>;<volume>23</volume>:<fpage>2050</fpage>–<lpage>2057</lpage>.<pub-id pub-id-type="pmid">23771818</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0024"><string-name><surname>Semenza</surname><given-names>GL</given-names></string-name>, <string-name><surname>Rue</surname><given-names>EA</given-names></string-name>, <string-name><surname>Iyer</surname><given-names>NV</given-names></string-name>, <string-name><surname>Pang</surname><given-names>MG</given-names></string-name>, <string-name><surname>Kearns</surname><given-names>MG</given-names></string-name>. <article-title>Assignment of the hypoxia‐inducible factor 1 alpha gene to a region of conserved synteny on mouse chromosome 12 and human chromosome 14q</article-title>. <source>Genomics</source>. <year>1996</year>;<volume>34</volume>:<fpage>437</fpage>–<lpage>439</lpage>.<pub-id pub-id-type="pmid">8786149</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0025"><string-name><surname>Hogenesch</surname><given-names>JB</given-names></string-name>, <string-name><surname>Chan</surname><given-names>WK</given-names></string-name>, <string-name><surname>Jackiw</surname><given-names>VH</given-names></string-name>, <string-name><surname>Brown</surname><given-names>RC</given-names></string-name>, <string-name><surname>Gu</surname><given-names>YZ</given-names></string-name>, <string-name><surname>Pray‐Grant</surname><given-names>M</given-names></string-name>, <string-name><surname>Perdew</surname><given-names>GH</given-names></string-name>, <string-name><surname>Bradfield</surname><given-names>CA</given-names></string-name>. <article-title>Characterization of a subset of the basic‐helix‐loop‐helix‐PAS superfamily that interacts with components of dioxin signaling pathway</article-title>. <source>J Biol Chem</source>. <year>1997</year>;<volume>272</volume>:<fpage>8581</fpage>–<lpage>8593</lpage>.<pub-id pub-id-type="pmid">9079689</pub-id></mixed-citation>
              </ref>
              <ref id="jah31645-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="jah31645-cit-0026"><string-name><surname>Kaluz</surname><given-names>S</given-names></string-name>, <string-name><surname>Kaluzova</surname><given-names>M</given-names></string-name>, <string-name><surname>Stanbridge</surname><given-names>EJ</given-names></string-name>. <article-title>Regulation of gene expression by hypoxia: integration of the HIF‐transduced hypoxic signal at the hypoxia‐responsive element</article-title>. <source>Clin Chim Acta</source>. <year>2008</year>;<volume>395</volume>:<fpage>6</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">18505681</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
